Sofie M. A. Walenbergh

1.1k citations

24 papers · 890 · h-index 18

Impact in

Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
Hepatology top 5%

Papers in

Epidemiology 13
- Liver Disease Diagnosis and Treatment 12
Molecular Biology 7
- Inflammasome and immune disorders 3
- Sphingolipid Metabolism and Signaling 3

Co-authors: Ronit Shiri‐Sverdlov (24 shared papers)Marten H. Hofker (14 shared papers)Tim Hendrikx (18 shared papers)Veerle Bieghs (9 shared papers)Patrick J. van Gorp (16 shared papers)Ger H. Koek (10 shared papers)Marion J. Gijbels (11 shared papers)Tom Houben (13 shared papers)
Journals: PLoS ONE (4 papers)Scientific Reports (3 papers)Journal of Hepatology (2 papers)Hepatology (2 papers)BMC Medicine (1 paper)
Partner nations: Netherlands Germany Austria

In The Last Decade

Sofie M. A. Walenbergh

24 papers receiving 881 citations

Peers

Countries citing papers authored by Sofie M. A. Walenbergh

Since Specialization

Citations

This map shows the geographic impact of Sofie M. A. Walenbergh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie M. A. Walenbergh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie M. A. Walenbergh more than expected).

Fields of papers citing papers by Sofie M. A. Walenbergh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofie M. A. Walenbergh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie M. A. Walenbergh. The network helps show where Sofie M. A. Walenbergh may publish in the future.

Co-authors

The 25 scholars most cited alongside Sofie M. A. Walenbergh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sofie M. A. Walenbergh Line = papers co-authored together Sofie M. A. Walenbergh links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice Hepatology ·Veerle Bieghs, Patrick J. van Gorp, Sofie M. A. Walenbergh, Marion J. Gijbels, Fons Verheyen, Wim A. Buurman, David E. Briles, Marten H. Hofker, Christoph J. Binder, Ronit Shiri‐Sverdlov	2012	81
2	Non-alcoholic steatohepatitis: The role of oxidized low-density lipoproteins Journal of Hepatology ·Sofie M. A. Walenbergh, Ger H. Koek, Veerle Bieghs, Ronit Shiri‐Sverdlov	2012	81
3	The Cholesterol Derivative 27-Hydroxycholesterol Reduces Steatohepatitis in Mice Gastroenterology ·Veerle Bieghs, Tim Hendrikx, Patrick J. van Gorp, Fons Verheyen, Yasmin Dias Guichot, Sofie M. A. Walenbergh, Mike L. J. Jeurissen, Marion J. Gijbels, Sander S. Rensen, Aalt Bast, Jogchum Plat, Satish C. Kalhan, Ger H. Koek, Eran Leitersdorf, Marten H. Hofker, Dieter Lütjohann, Ronit Shiri‐Sverdlov	2012	79
4	Trapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation Liver International ·Veerle Bieghs, Sofie M. A. Walenbergh, Tim Hendrikx, Patrick J. van Gorp, Fons Verheyen, Steven W.M. Olde Damink, Ad Masclee, Ger H. Koek, Marten H. Hofker, Christoph J. Binder, Ronit Shiri‐Sverdlov	2013	68
5	Lysosomal cholesterol accumulation: driver on the road to inflammation during atherosclerosis and non‐alcoholic steatohepatitis Obesity Reviews ·Tim Hendrikx, Sofie M. A. Walenbergh, Marten H. Hofker, Ronit Shiri‐Sverdlov	2014	67
6	Bone marrow‐specific caspase‐1/11 deficiency inhibits atherosclerosis development in Ldlr^−/− mice FEBS Journal ·Tim Hendrikx, Mike L. J. Jeurissen, Patrick J. van Gorp, Marion J. Gijbels, Sofie M. A. Walenbergh, Tom Houben, Rick van Gorp, Chantal C. H. Pöttgens, Rinke Stienstra, Mihai G. Netea, Marten H. Hofker, Marjo M. P. C. Donners, Ronit Shiri‐Sverdlov	2015	60
7	Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice Hepatology ·Clara Jana‐Lui Busch, Tim Hendrikx, David Weismann, Sven Jäckel, Sofie M. A. Walenbergh, André F. Rendeiro, Juliane Weißer, Florian Puhm, Anastasiya Hladik, Laura Göderle, Nikolina Papac-Miličević, G. G. de Haas, Vincent Millischer, Saravanan Subramaniam, Sylvia Knapp, Keiryn L. Bennett, Christoph Bock, Christoph Reinhardt, Ronit Shiri‐Sverdlov, Christoph J. Binder	2016	54
8	Cathepsin D regulates lipid metabolism in murine steatohepatitis Scientific Reports ·Tom Houben, Yvonne Oligschlaeger, Tim Hendrikx, Albert V. Bitorina, Sofie M. A. Walenbergh, Patrick J. van Gorp, Marion J. Gijbels, Silvia Friedrichs, Jogchum Plat, Frank G. Schaap, Dieter Lütjohann, Marten H. Hofker, Ronit Shiri‐Sverdlov	2017	50
9	Protective Role of Plant Sterol and Stanol Esters in Liver Inflammation: Insights from Mice and Humans PLoS ONE ·Jogchum Plat, Tim Hendrikx, Veerle Bieghs, Mike L. J. Jeurissen, Sofie M. A. Walenbergh, Patrick J. van Gorp, Els De Smet, Maurice Konings, Anita Vreugdenhil, Yasmin Dias Guichot, Sander S. Rensen, Wim A. Buurman, Jan Greve, Dieter Lütjohann, Ronald P. Mensink, Ronit Shiri‐Sverdlov	2014	44
10	Plasma Cathepsin D Levels: A Novel Tool to Predict Pediatric Hepatic Inflammation The American Journal of Gastroenterology ·Sofie M. A. Walenbergh, Tom Houben, Tim Hendrikx, Mike L. J. Jeurissen, Patrick J. van Gorp, Anita Vreugdenhil, Marlou Adriaanse, Wim A. Buurman, Marten H. Hofker, Antonella Mosca, Patrick Lindsey, Anna Alisi, Daniela Liccardo, Nadia Panera, Ger H. Koek, Valério Nobili, Ronit Shiri‐Sverdlov	2015	38
11	Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention Scientific Reports ·Sofie M. A. Walenbergh, Tom Houben, Sander S. Rensen, Veerle Bieghs, Tim Hendrikx, Patrick J. van Gorp, Yvonne Oligschlaeger, Mike L. J. Jeurissen, Marion J. Gijbels, Wim A. Buurman, Anita Vreugdenhil, Jan Greve, Jogchum Plat, Marten H. Hofker, Satish C. Kalhan, Jussi Pihlajamäki, Patrick Lindsey, Ger H. Koek, Ronit Shiri‐Sverdlov	2016	36
12	Cholesterol is a significant risk factor for non-alcoholic steatohepatitis Expert Review of Gastroenterology & Hepatology ·Sofie M. A. Walenbergh, Ronit Shiri‐Sverdlov	2015	31
13	Macrophage Specific Caspase-1/11 Deficiency Protects against Cholesterol Crystallization and Hepatic Inflammation in Hyperlipidemic Mice PLoS ONE ·Tim Hendrikx, Veerle Bieghs, Sofie M. A. Walenbergh, Patrick J. van Gorp, Fons Verheyen, Mike L. J. Jeurissen, M.M. Steinbusch, Nathalie Vaes, Christoph J. Binder, Ger H. Koek, Rinke Stienstra, Mihai G. Netea, Marten H. Hofker, Ronit Shiri‐Sverdlov	2013	30
14	Oxidized LDL at the crossroads of immunity in non-alcoholic steatohepatitis Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Tom Houben, Eelke Brandsma, Sofie M. A. Walenbergh, Marten H. Hofker, Ronit Shiri‐Sverdlov	2016	26
15	Hematopoietic overexpression of Cyp27a1 reduces hepatic inflammation independently of 27-hydroxycholesterol levels in Ldlr−/− mice Journal of Hepatology ·Tim Hendrikx, Mike L. J. Jeurissen, Veerle Bieghs, Sofie M. A. Walenbergh, Patrick J. van Gorp, Fons Verheyen, Tom Houben, Yasmin Dias Guichot, Marion J. Gijbels, Eran Leitersdorf, Marten H. Hofker, Dieter Lütjohann, Ronit Shiri‐Sverdlov	2014	26
16	Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease BMC Medicine ·Tim Hendrikx, Martin L. Watzenböck, Sofie M. A. Walenbergh, Shahzada Amir, Sabrina Gruber, Maria Ozsvar Kozma, Heike I. Grabsch, Ger H. Koek, Marieke Pierik, Katharina Staufer, Michael Trauner, Satish C. Kalhan, Daisy Jonkers, Marten H. Hofker, Christoph J. Binder, Ronit Shiri‐Sverdlov	2016	23
17	Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr−/− mice Atherosclerosis ·Mike L. J. Jeurissen, Sofie M. A. Walenbergh, Tom Houben, Marion J. Gijbels, Jieyi Li, Tim Hendrikx, Yvonne Oligschlaeger, Patrick J. van Gorp, Christoph J. Binder, Marjo M. P. C. Donners, Ronit Shiri‐Sverdlov	2016	22
18	Blood-derived macrophages prone to accumulate lysosomal lipids trigger oxLDL-dependent murine hepatic inflammation Scientific Reports ·Tom Houben, Yvonne Oligschlaeger, Albert V. Bitorina, Tim Hendrikx, Sofie M. A. Walenbergh, Marie-Hélène Lenders, Marion J. Gijbels, Fons Verheyen, Dieter Lütjohann, Marten H. Hofker, Christoph J. Binder, Ronit Shiri‐Sverdlov	2017	20
19	MSP is a negative regulator of inflammation and lipogenesis in ex vivo models of non-alcoholic steatohepatitis Experimental & Molecular Medicine ·Dipanjan Chanda, Jieyi Li, Yvonne Oligschlaeger, Mike L. J. Jeurissen, Tom Houben, Sofie M. A. Walenbergh, Ronit Shiri‐Sverdlov, Dietbert Neumann	2016	16
20	Macrophage Stimulating Protein Enhances Hepatic Inflammation in a NASH Model PLoS ONE ·Jieyi Li, Dipanjan Chanda, Patrick J. van Gorp, Mike L. J. Jeurissen, Tom Houben, Sofie M. A. Walenbergh, J.M.H. Debets, Yvonne Oligschlaeger, Marion J. Gijbels, Dietbert Neumann, Ronit Shiri‐Sverdlov	2016	15

About Sofie M. A. Walenbergh

Sofie M. A. Walenbergh is a scholar working on Epidemiology, Molecular Biology, Surgery, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 24 papers that have together received 890 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (12 papers), Diet, Metabolism, and Disease (3 papers), Inflammasome and immune disorders (3 papers), Cholesterol and Lipid Metabolism (3 papers), Sphingolipid Metabolism and Signaling (3 papers), Pancreatitis Pathology and Treatment (2 papers), Lipid metabolism and disorders (2 papers) and Hermeneutics and Narrative Identity (1 paper). The work is most often cited by research in Epidemiology (452 citations), Hepatology (102 citations), Endocrinology, Diabetes and Metabolism (149 citations), Cell Biology (125 citations) and Immunology (137 citations). Sofie M. A. Walenbergh has collaborated with scholars based in Netherlands, Germany and Austria. Frequent co-authors include Ronit Shiri‐Sverdlov, Marten H. Hofker, Tim Hendrikx, Veerle Bieghs, Patrick J. van Gorp, Ger H. Koek, Marion J. Gijbels, Tom Houben, Mike L. J. Jeurissen and Fons Verheyen. Their work appears in journals such as PLoS ONE, Scientific Reports, Journal of Hepatology, Hepatology and BMC Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Sofie M. A. Walenbergh

Impact in

Papers in i

In The Last Decade

Sofie M. A. Walenbergh

Peers

Countries citing papers authored by Sofie M. A. Walenbergh

Fields of papers citing papers by Sofie M. A. Walenbergh

All Works

About Sofie M. A. Walenbergh

Explore authors with similar magnitude of impact

Papers in